Enclosed please find the notice of and the complete proposals for the Annual
General Meeting of TORM A/S to be held on 26 March 2015.
Contact TORM A/S Tuborg Havnevej 18
Flemming Ipsen, Chairman, tel.: +45 3917 DK-2900 Hellerup, Denmark
9200 Tel.: +45 3917 9200 / Fax: +45
Jacob Meldgaard, CEO, tel.: +45 3917 9200 3917 9393
SHANGHAI, China, March 4, 2015 (GLOBE NEWSWIRE) -- Weibo Corporation (Nasdaq:WB), a leading social media platform for people to create, distribute and discover Chinese-language content, will announce its unaudited financial results for the fourth quarter 2014 after the close of market on March 10, 2015. Following the announcement, Weibo's management team will host a conference call from 9p.m. –10p.m. Eastern Time on March 10, 2015 (or 9a.m. –10a.m. Beijing Time on March 11, 2015) to present an overview of the Company's financial performance and business operations.
Dovre Group Plc Stock exchange bulletin March 4, 2015 at
NOTICE OF THE ANNUAL GENERAL MEETING OF DOVRE GROUP PLC
Notice is given to the shareholders of Dovre Group Plc of the Annual General
Meeting (‘AGM’) to be held on Wednesday, March 25, 2015, at 2.30 p.m. at
Suomalainen Klubi, Kansakoulukuja 3, Helsinki. The reception of the persons who
have registered for the meeting and the distribution of voting tickets will
commence at 2 p.m.
A. MATTERS ON THE AGENDA O
CAVERION CORPORATION STOCK EXCHANGE RELEASE MARCH 4, 2015 AT 14:15
Notification according to Chapter 9, Section 5 of the Securities Markets Act of
change in holdings in Caverion Corporation shares
Caverion Corporation (ID 2534127-4) has on March 4, 2015 received a disclosure
under Chapter 9, Section 5 of the Securities Markets Act, according to which
the holdings of Security Trading Ltd, a company controlled by Antti Herlin in
Caverion Corporation shares have exceeded
ASTRAZENECA TO PARTICIPATE IN US FDA ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY
AstraZeneca today announced it will participate in the US Food and Drug
Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee
meeting on 14 April 2015 to discuss the results of the Saxagliptin Assessment of
Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR) trial for
ONGLYZA® (saxagliptin) and Kombiglyze® XR (saxagliptin and metformin HCI
Data on Finasta Asset Management UAB issued investment funds units is presented
in the table as of March 3, 2015.
Fund Unit price, Issued Redeemed Total number of
EUR units units issued units
Finasta New Europe 29,6344 9,9723 66,7342 387884,4729
Finasta Russia TOP20 19,5219 2108,0846 1
GlobeNewswire, a NASDAQ OMX company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.